K
Market Data
$11.68+$1.62 (+16.10%)
KROS · Last trade
Prev Close
$10.06
Range (29d)
$9.97 – $11.68
Recent Filings
- 1444.9 KBKeros Therapeutics, Inc.Aug 18, 4:11 PM ET·0001969223-26-000924
- 8-K4.6 MBKeros Therapeutics, Inc.Aug 3, 4:07 PM ET·0001664710-26-000050
- 10-Q6.1 MBKeros Therapeutics, Inc.Aug 3, 4:02 PM ET·0001664710-26-000049
- 8-K256.9 KBKeros Therapeutics, Inc.Aug 3, 4:02 PM ET·0001664710-26-000048
- 8-K169.8 KBKeros Therapeutics, Inc.Jul 30, 4:01 PM ET·0001664710-26-000043
- SCHEDULE 13G/A10.9 KBKeros Therapeutics, Inc.Jul 29, 3:19 PM ET·0002012383-26-002890
- 8-K158.2 KBKeros Therapeutics, Inc.Jul 22, 4:01 PM ET·0001664710-26-000038
- 8-K178.1 KBKeros Therapeutics, Inc.Jun 25, 4:02 PM ET·0001664710-26-000036
- 8-K162.4 KBKeros Therapeutics, Inc.Jun 3, 4:01 PM ET·0001664710-26-000034
- 8-K162.4 KBKeros Therapeutics, Inc.Jun 1, 4:02 PM ET·0001664710-26-000032
Insiders
10- ADAR1 Capital Management, LLC10% Owner
- ADAR1 Partners, LP10% Owner
- Arkin Bio Ventures Limited Partnership10% Owner
- Arkin Moshe10% Owner
- BIENAIME JEAN JACQUESDirector
- Cho EstherChief Legal Officer
- CHYUNG YUNG H.Chief Medical Officer
- Cooper Simon PeterCHIEF MEDICAL OFFICER
- Farzan NimaDirector
- GORDON CARL LDirector
Tickers
Addresses
business
1050 WALTHAM STREET, SUITE 302
LEXINGTON, MA, 02421
mailing
1050 WALTHAM STREET, SUITE 302
LEXINGTON, MA, 02421